Stocks AMR Financial statements
Financial statementsAlpha Metallurgical Resources, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Alpha Metallurgical Resources, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,650 | 2,031 | 2,001 | 1,416 | 2,259 | 4,102 | 3,471 | 2,957 | 2,129 |
| Cost of revenue | 1,327 | 1,661 | 1,668 | 1,281 | 1,678 | 2,286 | 2,356 | 2,452 | 1,925 |
| Gross profit | 323 | 370 | 334 | 135 | 581 | 1,816 | 1,115 | 506 | 205 |
| Selling, general and administrative | 67.5 | 59.3 | 79 | 57.4 | 63.9 | 71.6 | 82.4 | 74 | 60.2 |
| Operating income | 182 | 194 | -169 | -171 | 359 | 1,581 | 863 | 228 | -61.4 |
| Interest expense | 36 | 38.8 | 67.5 | 74.5 | 69.7 | 21.8 | 6.92 | 3.81 | 3.02 |
| Interest income | 0.21 | 1.95 | 7.25 | 7.03 | 0.34 | 3.19 | 11.9 | 18.2 | 15.5 |
| Other non-operating income | -76.6 | -56.3 | -104 | -72.9 | -67 | -26.1 | -17.6 | -17.1 | -26.1 |
| Pre-tax income | 106 | 137 | -273 | -244 | 292 | 1,555 | 845 | 211 | -87.5 |
| Income tax | -68 | -165 | -53.3 | -2.16 | 3.41 | 106 | 124 | 23.2 | -25.8 |
| Income from continuing operations | 174 | 303 | -220 | -241 | 289 | 1,449 | 722 | ||
| Net income | 155 | 299 | -316 | -447 | 289 | 1,449 | 722 | 188 | -61.7 |
| EBITDA | 469 | 1,688 | 1,000 | 395 | 113 | ||||
| EPS, basic | 15.12 | 27.28 | -16.82 | -24.42 | 15.66 | 82.82 | 51.18 | 14.41 | -4.75 |
| EPS, diluted | 14.35 | 25.54 | -16.82 | -24.42 | 15.30 | 79.49 | 49.30 | 14.28 | -4.75 |
| Shares, basic (weighted) | 10.2 | 11 | 18.8 | 18.3 | 18.4 | 17.5 | 14.1 | 13 | 13 |
| Shares, diluted (weighted) | 10.8 | 11.7 | 18.8 | 18.3 | 18.9 | 18.2 | 14.6 | 13.1 | 13 |
| Dividend per share | 6.19 | 1.94 |
Balance sheet
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 142 | 234 | 213 | 139 | 81.2 | 302 | 268 | 482 | 366 |
| Short-term investments | 0 | 46.1 | 0 | 0 | 49.6 | ||||
| Receivables | 127 | 293 | 224 | 146 | 489 | 407 | 510 | 362 | 279 |
| Inventory | 69.6 | 122 | 151 | 108 | 129 | 201 | 231 | 169 | 193 |
| Other current assets | 83.8 | 159 | 77.7 | 106 | 35.8 | 49.4 | 39.1 | 23.7 | 31.1 |
| Total current assets | 463 | 830 | 711 | 510 | 748 | 1,114 | 1,048 | 1,037 | 918 |
| Property, plant and equipment | 180 | 700 | 583 | 364 | 362 | 443 | 589 | 635 | 622 |
| Lease right-of-use assets | 0 | 7.3 | 5.67 | 5 | 4.49 | 4.04 | 3.56 | 5.34 | |
| Goodwill | 0 | 95.6 | 0 | 0 | 10.7 | 11.1 | 11.1 | 11.1 | |
| Intangible assets | 18.5 | 155 | 124 | 88.2 | 74.2 | 55.1 | 46.6 | 39.9 | 34.5 |
| Other non-current assets | 31.6 | 184 | 189 | 149 | 109 | 103 | 106 | 112 | 120 |
| Total assets | 837 | 2,746 | 2,303 | 1,680 | 1,858 | 2,312 | 2,406 | 2,439 | 2,281 |
| Accounts payable | 76.3 | 115 | 82.7 | 58.4 | 90.1 | 106 | 129 | 96.6 | 66.2 |
| Accrued liabilities | 58.8 | 149 | 139 | 140 | 53.6 | 69.5 | 62.8 | 48.6 | 46.7 |
| Deferred revenue | 0 | 13.2 | 0 | ||||||
| Short-term debt | 42.7 | 28.5 | 28.8 | 2.99 | 3.08 | 3.58 | 2.92 | 3.58 | |
| Total current liabilities | 242 | 355 | 315 | 259 | 296 | 403 | 310 | 251 | 206 |
| Long-term debt | 362 | 545 | 564 | 554 | 446 | 7.9 | 6.79 | 2.87 | 9.84 |
| Lease liabilities | 0 | 5.9 | 5.08 | 4.46 | 3.88 | 3.47 | 2.97 | 4.65 | |
| Other non-current liabilities | 17.6 | 52.4 | 26.8 | 28.1 | 26.2 | 20.2 | 18.6 | 21.4 | 21.3 |
| Total liabilities | 744 | 1,675 | 1,607 | 1,480 | 1,311 | 883 | 832 | 789 | 735 |
| Total debt | 362 | 633 | 623 | 600 | 455 | 6.18 | 5.1 | 1.79 | 3.86 |
| Paid-in capital | 40.6 | 761 | 776 | 779 | 785 | 815 | 834 | 840 | 852 |
| Retained earnings | 104 | 403 | 86.8 | -361 | -71.7 | 1,275 | 1,970 | 2,156 | 2,095 |
| Treasury stock | -50.1 | -70.4 | -108 | -107 | -108 | -649 | -1,190 | -1,297 | -1,341 |
| Other comprehensive income | -1.95 | -23.1 | -58.6 | -112 | -58.5 | -12.2 | -40.6 | -50.1 | -60.4 |
| Shareholders' equity | 92.6 | 1,071 | 696 | 200 | 547 | 1,430 | 1,574 | 1,649 | 1,545 |
| Total equity | 92.6 | 1,071 | 696 | 200 | 547 | 1,430 | 1,574 | 1,649 | 1,545 |
| Total liabilities and equity | 837 | 2,746 | 2,303 | 1,680 | 1,858 | 2,312 | 2,406 | 2,439 | 2,281 |
| Shares outstanding | 9.9 | 19.1 | 18.2 | 18.3 | 18.4 | 15.6 | 12.9 | 13 | 12.8 |
Cash flow statement
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | 155 | 299 | -316 | -447 | 289 | 1,449 | 722 | 188 | -61.7 |
| Depreciation and amortization | 110 | 108 | 137 | 167 | 175 | ||||
| Stock-based compensation | 20.4 | 13.4 | 12.4 | 4.9 | 5.32 | 7.48 | 19 | 12.3 | 13.6 |
| Deferred income tax | -78.7 | -66.7 | -12.1 | 33.1 | -0.16 | -14.5 | 39.7 | 5.56 | -23.7 |
| Change in receivables | 34.8 | -84.1 | 47.4 | 91.2 | -336 | 82.8 | -102 | 145 | 83.4 |
| Change in inventory | 0.44 | 33.2 | -40.7 | 48.7 | -21.3 | -63.2 | -27.9 | 64.2 | -21.5 |
| Change in payables | 6.1 | -7.08 | -28.1 | -28.6 | 25.2 | 3.72 | 15.7 | -19.3 | -29.1 |
| Cash from operations | 314 | 158 | 132 | 129 | 175 | 1,484 | 851 | 580 | 145 |
| Capital expenditures | -72.7 | -81.9 | -160 | -120 | -83.3 | -164 | -245 | -199 | -127 |
| Acquisitions | 0 | 0 | -24.9 | -11.9 | 0 | 0 | |||
| Purchases of investments | -0.41 | -3.28 | -92.9 | -21.1 | -18 | -269 | -207 | -48.7 | -106 |
| Sales and maturities of investments | 0 | 3.36 | 100 | 16.7 | 13.3 | 149 | 321 | 48 | 67.2 |
| Cash from investing | -121 | 102 | -192 | -210 | -89.9 | -329 | -166 | -231 | -204 |
| Debt issued | 396 | 538 | 545 | 57.5 | 0 | 0 | |||
| Debt repaid | -370 | -472 | -553 | -76.5 | -119 | -451 | -2.31 | -2.24 | -1.97 |
| Share buybacks | -49.9 | -20.3 | -37.6 | -0.21 | -0.79 | -522 | |||
| Dividends paid | -101 | 0 | 0 | 0 | 0 | -13.4 | -26.8 | -3.08 | -0.42 |
| Cash from financing | -170 | 22.7 | -69.7 | -22.4 | -147 | -982 | -656 | -129 | -52.2 |
| Net change in cash | 22.7 | 283 | -130 | -103 | -62 | 173 | 28.7 | 220 | -111 |
| Free cash flow | 242 | 76.5 | -28.6 | 9.66 | 91.6 | 1,320 | 606 | 381 | 17.8 |
| Interest paid | 40.6 | 27.3 | 51.9 | 49.3 | 63.1 | 25.9 | 5.21 | 2.66 | 1.87 |
| Income taxes paid | 13.3 | 0.04 | 3.04 | 0.01 | 0.18 | 140 | 79.2 | 8.38 | 2.12 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 10.0% | Gross profit / revenue. |
| Operating margin | -2.2% | Operating income / revenue. |
| EBITDA margin | 5.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -3.4% | Pre-tax income / revenue. |
| Net margin | -2.2% | Net income / revenue. |
| FCF margin | -0.1% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 6.7% | Cash from operations / revenue. |
| Return on equity (ROE) | -3.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -2.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | -3.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 3.1% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.7% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 6.8% | Capital expenditures / revenue. |
| D&A / revenue | 7.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -28.0% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -19.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 8.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -59.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -51.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 8.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -126.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -71.4% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -59.4% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -132.9% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -133.3% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -75.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -53.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 2.3% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -95.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -76.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 13.0% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -6.3% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 2.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 50.5% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -6.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -0.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 6.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -1.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -10.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -6.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.41x | Current assets / current liabilities. |
| Quick ratio | 2.25x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.34x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.00x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 0.1% | Total debt / total assets. |
| Liabilities / assets | 33.6% | Total liabilities / total assets. |
| Net debt | -$335.5M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -2.87x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | -13.6x | Operating income / interest expense. |
| Working capital | $609.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 1.4% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $1.47B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.92x | Revenue / average total assets. |
| Fixed asset turnover | 3.24x | Revenue / average property, plant and equipment. |
| Inventory turnover | 7.08x | Cost of revenue / average inventory. |
| Days inventory | 52 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 8.96x | Revenue / average receivables. |
| Days sales outstanding | 41 days | 365 x average receivables / revenue. |
| Days payables | 17 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 75 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 101.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$3.62 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $162.43 | Revenue / diluted weighted shares. |
| FCF per share | -$0.11 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $10.89 | Cash from operations / diluted weighted shares. |
| Book value per share | $118.15 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $115.57 | Tangible book value / shares outstanding. |
| Cash per share | $26.68 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $2.21B | Share price x shares outstanding. |
| Enterprise value | $1.88B | Market cap + total debt - cash - short-term investments. |
| P/S | 1.07x | Market cap / revenue. |
| P/B | 1.48x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.51x | Market cap / tangible book value, when positive. |
| P/OCF | 16.0x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.91x | Enterprise value / revenue. |
| EV/EBITDA | 16.0x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -0.1% | Free cash flow / market cap. |
| Earnings yield | -2.1% | Net income / market cap (the inverse of P/E). |
What was Alpha Metallurgical Resources, Inc.'s revenue in fiscal 2025?
Alpha Metallurgical Resources, Inc. reported revenue of $2.13B for fiscal 2025, 28% lower than the year before.
Was Alpha Metallurgical Resources, Inc. profitable in fiscal 2025?
No. It reported a net loss of $61.7M.
How much free cash flow did Alpha Metallurgical Resources, Inc. generate in fiscal 2025?
Cash from operations of $144.9M minus capital expenditures of $127.2M left free cash flow of $17.8M.